(Q42451992)

English

The dietary polyphenols trans-resveratrol and curcumin selectively bind human CB1 cannabinoid receptors with nanomolar affinities and function as antagonists/inverse agonists

scientific article published on 9 April 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 October 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

The dietary polyphenols trans-resveratrol and curcumin selectively bind human CB1 cannabinoid receptors with nanomolar affinities and function as antagonists/inverse agonists (English)

1 reference

Europe PubMed Central

31 October 2017

0 references

0 references

cannabinoid receptor

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Kathryn A Seely

1

1 reference

Europe PubMed Central

31 October 2017

Mark S Levi

2

1 reference

Europe PubMed Central

31 October 2017

Paul L Prather

3

1 reference

Europe PubMed Central

31 October 2017

language of work or name

0 references

publication date

9 April 2009

1 reference

Europe PubMed Central

31 October 2017

Journal of Pharmacology and Experimental Therapeutics

1 reference

Europe PubMed Central

31 October 2017

330

1 reference

Europe PubMed Central

31 October 2017

31-39

1 reference

Europe PubMed Central

31 October 2017

1

1 reference

Europe PubMed Central

31 October 2017

Therapeutic potential of resveratrol: the in vivo evidence

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Bioavailability of curcumin: problems and promises

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa).

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Oxidative breakage of cellular DNA by plant polyphenols: a putative mechanism for anticancer properties.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Blocking the cannabinoid receptors: drug candidates and therapeutic promises

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

End of the line for cannabinoid receptor 1 as an anti-obesity target? An opinion.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: the role of GLUT-4 and endothelin.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Antioxidant availability of turmeric in relation to its medicinal and culinary uses

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Resorcinol derivatives: a novel template for the development of cannabinoid CB(1)/CB(2) and CB(2)-selective agonists

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Specific plasma membrane binding sites for polyphenols, including resveratrol, in the rat brain.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Challenges for research on polyphenols from foods in Alzheimer's disease: bioavailability, metabolism, and cellular and molecular mechanisms.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor?

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Nutraceuticals: facts and fiction

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Regulation of inflammation and redox signaling by dietary polyphenols

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Redox-sensitive transcription factors as prime targets for chemoprevention with anti-inflammatory and antioxidative phytochemicals

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

End of the line for cannabinoid receptor 1 as an anti-obesity target?

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

The inhibition of human glutathione S-transferases activity by plant polyphenolic compounds ellagic acid and curcumin

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Inhibition of glycogen synthase kinase by curcumin: Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Plant polyphenols: how to translate their in vitro antioxidant actions to in vivo conditions

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Polyphenolic phytochemicals--just antioxidants or much more?

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Identification of novel cannabinoid CB1 receptor antagonists by using virtual screening with a pharmacophore model

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Crystal structure of quinone reductase 2 in complex with resveratrol

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Inhibition of cancer growth by resveratrol is related to its low bioavailability

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Cannabinoid-based drugs as anti-inflammatory therapeutics

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Central versus peripheral antagonism of cannabinoid CB1 receptor in obesity: effects of LH-21, a peripherally acting neutral cannabinoid receptor antagonist, in Zucker rats.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Dietary polyphenols and the prevention of diseases.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1124/JPET.109.151654

Identifiers

10.1124/JPET.109.151654

1 reference

Europe PubMed Central

31 October 2017

1 reference

Europe PubMed Central

31 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42451992&oldid=2042412166"